175 related articles for article (PubMed ID: 32582990)
1. E2F7, regulated by miR‑30c, inhibits apoptosis and promotes cell cycle of prostate cancer cells.
Wang Y; Pei X; Xu P; Tan Z; Zhu Z; Zhang G; Jiang Z; Deng Z
Oncol Rep; 2020 Sep; 44(3):849-862. PubMed ID: 32582990
[TBL] [Abstract][Full Text] [Related]
2. miR‑30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.
Huang YQ; Ling XH; Yuan RQ; Chen ZY; Yang SB; Huang HX; Zhong WD; Qiu SP
Mol Med Rep; 2017 Sep; 16(3):2431-2438. PubMed ID: 28677791
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
Lu T; Wang R; Cai H; Cui Y
Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
[TBL] [Abstract][Full Text] [Related]
4. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
5. Circ-CCS is identified as a cancer-promoting circRNA in lung cancer partly by regulating the miR-383/E2F7 axis.
Yuan Y; Zhou X; Kang Y; Kuang H; Peng Q; Zhang B; Liu X; Zhang M
Life Sci; 2021 Feb; 267():118955. PubMed ID: 33359669
[TBL] [Abstract][Full Text] [Related]
6. The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells.
Salvatori B; Iosue I; Mangiavacchi A; Loddo G; Padula F; Chiaretti S; Peragine N; Bozzoni I; Fazi F; Fatica A
Cell Death Dis; 2012 Oct; 3(10):e413. PubMed ID: 23096114
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
Teng F; Zhang JX; Chang QM; Wu XB; Tang WG; Wang JF; Feng JF; Zhang ZP; Hu ZQ
J Exp Clin Cancer Res; 2020 Nov; 39(1):235. PubMed ID: 33168027
[TBL] [Abstract][Full Text] [Related]
8. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7.
Zhao Y; Zhu C; Chang Q; Peng P; Yang J; Liu C; Liu Y; Chen X; Liu Y; Cheng R; Wu Y; Wu X; Hu L; Yin J
PLoS One; 2020; 15(11):e0242179. PubMed ID: 33201900
[TBL] [Abstract][Full Text] [Related]
9. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
Wang C; Li S; Xu J; Niu W; Li S
Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
[TBL] [Abstract][Full Text] [Related]
10. E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription.
Hao F; Wang N; Zhang Y; Xu W; Chen Y; Fei X; Wang J
Mol Carcinog; 2022 Nov; 61(11):975-988. PubMed ID: 35924788
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
[TBL] [Abstract][Full Text] [Related]
12. LncRNA CASC19 contributed to the progression of pancreatic cancer through modulating miR-148b/E2F7 axis.
Lu T; Wei GH; Wang J; Shen J
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10462-10471. PubMed ID: 33155202
[TBL] [Abstract][Full Text] [Related]
13. CTCF-induced upregulation of HOXA11-AS facilitates cell proliferation and migration by targeting miR-518b/ACTN4 axis in prostate cancer.
Xing Z; Li S; Liu Z; Zhang C; Bai Z
Prostate; 2020 Apr; 80(5):388-398. PubMed ID: 31971633
[TBL] [Abstract][Full Text] [Related]
14. Long non-‑coding RNA SNHG16 functions as a tumor activator by sponging miR‑373‑3p to regulate the TGF‑β‑R2/SMAD pathway in prostate cancer.
Weng W; Liu C; Li G; Ruan Q; Li H; Lin N; Chen G
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643247
[TBL] [Abstract][Full Text] [Related]
15. MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
Erdmann K; Kaulke K; Rieger C; Salomo K; Wirth MP; Fuessel S
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2249-61. PubMed ID: 27562865
[TBL] [Abstract][Full Text] [Related]
16. CircPRKCI-miR-545/589-E2F7 axis dysregulation mediates hydrogen peroxide-induced neuronal cell injury.
Cheng Q; Cao X; Xue L; Xia L; Xu Y
Biochem Biophys Res Commun; 2019 Jun; 514(2):428-435. PubMed ID: 31053300
[TBL] [Abstract][Full Text] [Related]
17. E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter.
Chu J; Zhu Y; Liu Y; Sun L; Lv X; Wu Y; Hu P; Su F; Gong C; Song E; Liu B; Liu Q
Oncotarget; 2015 Oct; 6(31):31944-57. PubMed ID: 26397135
[TBL] [Abstract][Full Text] [Related]
18. The protective role of all-transretinoic acid (ATRA) against colorectal cancer development is achieved via increasing miR-3666 expression and decreasing E2F7 expression.
Liu W; Song Y; Zhang C; Gao P; Huang B; Yang J
Biomed Pharmacother; 2018 Aug; 104():94-101. PubMed ID: 29772445
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.
Zhou YJ; Yang HQ; Xia W; Cui L; Xu RF; Lu H; Xue Z; Zhang B; Tian ZN; Cao YJ; Xing ZY; Yin S; He XZ
Life Sci; 2017 Dec; 190():7-14. PubMed ID: 28943214
[TBL] [Abstract][Full Text] [Related]
20. The prostate cancer-up-regulated Myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptor.
Jiao L; Li Y; Shen D; Xu C; Wang L; Huang G; Chen L; Yang Y; Yang C; Yu Y; Sun Y
Med Oncol; 2013; 30(2):570. PubMed ID: 23609189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
